Tweet
LONDON: Scientists in Britain have applied for a license to create hybrid embryos using human cells and animal eggs for stem cell research to develop new treatments for diseases such as Parkinson's, stroke and Alzheimer's.
The researchers from Kings College London and the North East England Stem Cell Institute (NESCI) submitted the application to the Human Fertilization and Embryology Authority (HFEA), a regulatory body that oversees embryo research and fertility treatment.
If the application is approved, the hybrid embryo will be 99.9% human and 0.1% animal. By using animal eggs, the scientists hope to overcome the shortage of human eggs left over from IVF treatments, which have been used for stem cell research.
"Our research team at King's College London is optimistic that the HFEA will rule favourably on our license application," said Stephen Minger, director of the Stem Cell Biology Laboratory at Kings College.
"We feel that the development of disease-specific human embryonic stem cell lines from individuals suffering from genetic forms of neurodegenerative disorders will ...
The researchers from Kings College London and the North East England Stem Cell Institute (NESCI) submitted the application to the Human Fertilization and Embryology Authority (HFEA), a regulatory body that oversees embryo research and fertility treatment.
If the application is approved, the hybrid embryo will be 99.9% human and 0.1% animal. By using animal eggs, the scientists hope to overcome the shortage of human eggs left over from IVF treatments, which have been used for stem cell research.
"Our research team at King's College London is optimistic that the HFEA will rule favourably on our license application," said Stephen Minger, director of the Stem Cell Biology Laboratory at Kings College.
"We feel that the development of disease-specific human embryonic stem cell lines from individuals suffering from genetic forms of neurodegenerative disorders will ...
�-)��O.o���]״)���
Comment